Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Twist Bioscience Corp (NASDAQ: TWST) closed the day trading at $46.70 down -1.87% from the previous closing price of $47.59. In other words, the price has decreased by -$1.87 from its previous closing price. On the day, 1.03 million shares were traded.
Ratios:
For a better understanding of TWST, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.62 and its Current Ratio is at 4.96. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on December 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $60.
On June 04, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $53.
Goldman Upgraded its Neutral to Buy on January 17, 2024, whereas the target price for the stock was revised from $25 to $45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 07 ’25 when CHESS ROBERT sold 2,940 shares for $53.13 per share. The transaction valued at 156,217 led to the insider holds 18,173 shares of the business.
Chess Robert Bruce bought 2,940 shares of TWST for $156,215 on Feb 07 ’25. On Feb 03 ’25, another insider, WERNER ROBERT F., who serves as the Chief Accounting Officer of the company, sold 185 shares for $49.35 each. As a result, the insider received 9,130 and left with 52,858 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.44 while its Price-to-Book (P/B) ratio in mrq is 6.10.
Stock Price History:
Over the past 52 weeks, TWST has reached a high of $60.90, while it has fallen to a 52-week low of $27.41. The 50-Day Moving Average of the stock is -4.21%, while the 200-Day Moving Average is calculated to be 0.08%.
Shares Statistics:
A total of 59.58M shares are outstanding, with a floating share count of 56.34M. Insiders hold about 5.55% of the company’s shares, while institutions hold 105.83% stake in the company.
Earnings Estimates
The dynamic stock of Twist Bioscience Corp (TWST) is currently attracting attention from 4.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.55, with high estimates of -$0.54 and low estimates of -$0.56.
Analysts are recommending an EPS of between -$1.99 and -$2.83 for the fiscal current year, implying an average EPS of -$2.23. EPS for the following year is -$1.74, with 6.0 analysts recommending between -$1.42 and -$2.45.
Revenue Estimates
10 analysts predict $92M in revenue for the current quarter. It ranges from a high estimate of $92.5M to a low estimate of $91.69M. As of the current estimate, Twist Bioscience Corp’s year-ago sales were $75.3MFor the next quarter, 10 analysts are estimating revenue of $95.71M. There is a high estimate of $97M for the next quarter, whereas the lowest estimate is $94.7M.
A total of 11 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $378.5M, while the lowest revenue estimate was $372.75M, resulting in an average revenue estimate of $376.08M. In the same quarter a year ago, actual revenue was $312.97MBased on 11 analysts’ estimates, the company’s revenue will be $441.57M in the next fiscal year. The high estimate is $447.3M and the low estimate is $427M.
